Literature DB >> 26339407

Interleukin-8 is a prognostic indicator in human hilar cholangiocarcinoma.

Qi Sun1, Fanni Li2, Fengkai Sun3, Jun Niu1.   

Abstract

Interleukin-8 (IL-8), matrix metalloproteinase-9 (MMP-9) and neovascularization have been implicated to be associated with biological processes, especially cancer progression. However, few studies have investigated the role of IL-8 in human hilar cholangiocarcinoma. In this study we detected the expression of IL-8 combined with MMP-9 and microvessel density (MVD) in hilar cholangiocarcinoma to evaluate their clinicopathological significance and prognostic value. A total of 62 patients with hilar cholangiocarcinoma who underwent curative surgery were enrolled in this study. The expression of IL-8, MMP-9 and MVD were examined immunohistochemically. The correlation of IL-8 with MMP-9 expression, MVD, clinicopathological features and survival time of patients were then analyzed. Expression of IL-8 was observed in 56.5% tumors, which was related to advanced TNM stage (P = 0.026) and tumor recurrence (P = 0.018). IL-8 had a positive correlation with MMP-9 expression and MVD. Furthermore, patients with high IL-8 expression had a significantly shorter overall survival than those with low IL-8 expression (P = 0.01). Multivariate analysis confirmed IL-8 as an independent prognostic factor (P = 0.005). In conclusion, IL-8 expression significantly correlated with MMP-9 expression and MVD, and IL-8 was a valuable prognostic factor for human hilar cholangiocarcinoma.

Entities:  

Keywords:  Cholangiocarcinoma; IL-8; immunohistochemistry; prognosis

Mesh:

Substances:

Year:  2015        PMID: 26339407      PMCID: PMC4555735     

Source DB:  PubMed          Journal:  Int J Clin Exp Pathol        ISSN: 1936-2625


  38 in total

1.  Outcome of surgical treatment of hilar cholangiocarcinoma: a special reference to postoperative morbidity and mortality.

Authors:  Satoshi Hirano; Satoshi Kondo; Eiichi Tanaka; Toshiaki Shichinohe; Takahiro Tsuchikawa; Kentaro Kato; Joe Matsumoto; Ryosuke Kawasaki
Journal:  J Hepatobiliary Pancreat Sci       Date:  2009-10-08       Impact factor: 7.027

Review 2.  Surgical management of proximal bile duct cancers.

Authors:  Jennifer LaFemina; William R Jarnagin
Journal:  Langenbecks Arch Surg       Date:  2012-03-06       Impact factor: 3.445

3.  SNAIL regulates interleukin-8 expression, stem cell-like activity, and tumorigenicity of human colorectal carcinoma cells.

Authors:  Wei-Lun Hwang; Muh-Hwa Yang; Ming-Long Tsai; Hsin-Yi Lan; Shu-Han Su; Shih-Ching Chang; Hao-Wei Teng; Shung-Haur Yang; Yuan-Tzu Lan; Shih-Hwa Chiou; Hsei-Wei Wang
Journal:  Gastroenterology       Date:  2011-04-16       Impact factor: 22.682

4.  Interleukin-8, a promising predictor for prognosis of pancreatic cancer.

Authors:  Ying Chen; Min Shi; Guan-Zhen Yu; Xiao-Ran Qin; Gang Jin; Peng Chen; Ming-Hua Zhu
Journal:  World J Gastroenterol       Date:  2012-03-14       Impact factor: 5.742

Review 5.  Influence of IL-8 on the epithelial-mesenchymal transition and the tumor microenvironment.

Authors:  Claudia Palena; Duane H Hamilton; Romaine I Fernando
Journal:  Future Oncol       Date:  2012-06       Impact factor: 3.404

6.  IL-8 increases integrin expression and cell motility in human chondrosarcoma cells.

Authors:  Chun-Yi Lee; Chun-Yin Huang; Meng-Yi Chen; Ching-Yuang Lin; Horng-Chaung Hsu; Chih-Hsin Tang
Journal:  J Cell Biochem       Date:  2011-09       Impact factor: 4.429

Review 7.  Hilar cholangiocarcinoma: current management.

Authors:  Fumito Ito; Clifford S Cho; Layton F Rikkers; Sharon M Weber
Journal:  Ann Surg       Date:  2009-08       Impact factor: 12.969

8.  Microvessel density correlates with lymph node metastases and prognosis in hilar cholangiocarcinoma.

Authors:  Armin Thelen; Arne Scholz; Christoph Benckert; Maik Schröder; Wilko Weichert; Bertram Wiedenmann; Peter Neuhaus; Sven Jonas
Journal:  J Gastroenterol       Date:  2008-12-24       Impact factor: 7.527

9.  Tumor-associated lymphangiogenesis correlates with lymph node metastases and prognosis in hilar cholangiocarcinoma.

Authors:  Armin Thelen; Arne Scholz; Christoph Benckert; Wilko Weichert; Ekkehart Dietz; Bertram Wiedenmann; Peter Neuhaus; Sven Jonas
Journal:  Ann Surg Oncol       Date:  2008-01-03       Impact factor: 5.344

10.  As an independent unfavorable prognostic factor, IL-8 promotes metastasis of nasopharyngeal carcinoma through induction of epithelial-mesenchymal transition and activation of AKT signaling.

Authors:  Xin-Jian Li; Li-Xia Peng; Jian-Yong Shao; Wen-Hua Lu; Jia-Xing Zhang; Shi Chen; Zhi-Yuan Chen; Yan-Qun Xiang; Ying-Na Bao; Fang-Jing Zheng; Mu-Sheng Zeng; Tie-Bang Kang; Yi-Xin Zeng; Bin Tean Teh; Chao-Nan Qian
Journal:  Carcinogenesis       Date:  2012-05-18       Impact factor: 4.944

View more
  9 in total

1.  Genetic Variant of CXCR1 (rs2234671) Associates with Clinical Outcome in Perihilar Cholangiocarcinoma.

Authors:  Isabella Lurje; Zoltan Czigany; Jan Bednarsch; Nadine Therese Gaisa; Edgar Dahl; Ruth Knüchel; Hannah Miller; Tom Florian Ulmer; Pavel Strnad; Christian Trautwein; Frank Tacke; Ulf Peter Neumann; Georg Lurje
Journal:  Liver Cancer       Date:  2022-01-25       Impact factor: 12.430

2.  Interleukin-8 produced from cancer-associated fibroblasts suppresses proliferation of the OCUCh-LM1 cancer cell line.

Authors:  Ryota Tanaka; Kenjiro Kimura; Shimpei Eguchi; Go Ohira; Shogo Tanaka; Ryosuke Amano; Hiroaki Tanaka; Masakazu Yashiro; Masaichi Ohira; Shoji Kubo
Journal:  BMC Cancer       Date:  2022-07-08       Impact factor: 4.638

3.  Attenuation of CD47-SIRPα Signal in Cholangiocarcinoma Potentiates Tumor-Associated Macrophage-Mediated Phagocytosis and Suppresses Intrahepatic Metastasis.

Authors:  Kulthida Vaeteewoottacharn; Ryusho Kariya; Phattarin Pothipan; Sawako Fujikawa; Chawalit Pairojkul; Sakda Waraasawapati; Kazuhiko Kuwahara; Chaisiri Wongkham; Sopit Wongkham; Seiji Okada
Journal:  Transl Oncol       Date:  2018-11-09       Impact factor: 4.243

Review 4.  Prognostic and Predictive Molecular Markers in Cholangiocarcinoma.

Authors:  Sandra Pavicevic; Sophie Reichelt; Deniz Uluk; Isabella Lurje; Cornelius Engelmann; Dominik P Modest; Uwe Pelzer; Felix Krenzien; Nathanael Raschzok; Christian Benzing; Igor M Sauer; Sebastian Stintzing; Frank Tacke; Wenzel Schöning; Moritz Schmelzle; Johann Pratschke; Georg Lurje
Journal:  Cancers (Basel)       Date:  2022-02-17       Impact factor: 6.639

5.  Profile of soluble factors in pleural effusions predict prognosis in mesothelioma.

Authors:  I M Dick; Y C G Lee; H M Cheah; A Miranda; B W S Robinson; J Creaney
Journal:  Cancer Biomark       Date:  2022       Impact factor: 4.388

6.  CCAR2 negatively regulates IL-8 production in cervical cancer cells.

Authors:  Wootae Kim; Jaehyuk Pyo; Byeong-Joo Noh; Joo-Won Jeong; Juhie Lee; Ja-Eun Kim
Journal:  Oncotarget       Date:  2017-12-13

7.  ACGH detects distinct genomic alterations of primary intrahepatic cholangiocarcinomas and matched lymph node metastases and identifies a poor prognosis subclass.

Authors:  Ruben Jansen; Birte Moehlendick; Christoph Bartenhagen; Csaba Tóth; Nadja Lehwald; Nikolas H Stoecklein; Wolfram T Knoefel; Anja Lachenmayer
Journal:  Sci Rep       Date:  2018-07-13       Impact factor: 4.379

8.  Circulating levels of soluble urokinase plasminogen activator receptor predict outcome after resection of biliary tract cancer.

Authors:  Sven H Loosen; Annemarie Breuer; Frank Tacke; Jakob N Kather; Joao Gorgulho; Patrick H Alizai; Jan Bednarsch; Anjali A Roeth; Georg Lurje; Sophia M Schmitz; Jonathan F Brozat; Pia Paffenholz; Mihael Vucur; Thomas Ritz; Alexander Koch; Christian Trautwein; Tom F Ulmer; Christoph Roderburg; Thomas Longerich; Ulf P Neumann; Tom Luedde
Journal:  JHEP Rep       Date:  2020-01-31

9.  Homophilic Interaction of CD147 Promotes IL-6-Mediated Cholangiocarcinoma Invasion via the NF-κB-Dependent Pathway.

Authors:  Paweena Dana; Ryusho Kariya; Worachart Lert-Itthiporn; Wunchana Seubwai; Saowaluk Saisomboon; Chaisiri Wongkham; Seiji Okada; Sopit Wongkham; Kulthida Vaeteewoottacharn
Journal:  Int J Mol Sci       Date:  2021-12-16       Impact factor: 5.923

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.